Related Image: Fountain of Youth to be found in the anthill? |
(Date:1/7/2009)... A study published in Cancer Prevention Research ... Research, identifies components of black raspberr...s at the Ohio State Comprehensive Cancer Center fo...ack raspberries, inhibited growth and stimulated a...esophageal carcinogen. , "Our data provide stro...
(Date:1/7/2009)...Fla. Mercury pollution has already spurred public...it could become a more pressing concern in a warme... recent issue of the journal Oecologia . , Sue ...University of Florida and the paper,s lead author,...ing in air enriched with carbon dioxide to soil be...
(Date:1/7/2009)...new discovery shows the four-eyed spookfish to be ...ther than lenses, to focus light in its eyes. , ...Bristol, said: "In nearly 500 million years of ver...e species living and dead, this is the only one kn... faced by all eyes how to make an image using a ...
(Date:1/7/2009)...Ohio Influenza,s ability to resist the effects of...ssia should serve as a cautionary tale about U.S. ... widespread avian flu infection in humans, scienti...e sequences of avian influenza strains to document...a class of antiviral drugs called adamantanes and ...
Breaking Biology News(10 mins):To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3Spookfish uses mirrors for eyes 2Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Pitt researchers create nontoxic clean up method for potentially toxic nano materials 9711 1Pitt researchers create nontoxic clean up method for potentially toxic nano materials 9711 2MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 32539 1MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 32539 2MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 32539 3FDA Wants New Diabetes Drugs Tested for Heart Risks 32536 1FDA Wants New Diabetes Drugs Tested for Heart Risks 32536 2Fears of promiscuity pose barrier to cervical cancer vaccinations 32533 1Fears of promiscuity pose barrier to cervical cancer vaccinations 32533 2...ing relatives-the world,s apes, monkeys, lemurs an... and some could soon disappear forever, according ...st Group of IUCN-The World Conservation Union,s Sp...nal Primatological Society (IPS), in collaboration...in Peril: The World,s 25 Most Endangered Primates-...
...nome Research Institute (NHGRI), one of the Nation...t the Large-Scale Sequencing Research Network will...rganisms, including the marmoset, a skate and seve...rt to expand understanding of the human genome. ,...search, which is a federally chartered committee t...
...overed that mammalian cells infected with HIV-1 en...usly observed only in plants and invertebrates. Th...ully thwarts this rare form of immunity in vertebr...IV-1 uses to protect itself provides some critical... HIV-1 molecule. Identification of what might be a...
...l Weapons Defense: Infectious Disease and Counterb...of disease. Published by Humana Press, this text i...rs come from the U.S. Army Medical Research Instit...s premier biodefense laboratory. , In this 624-pag...nk J. Lebeda, and George W. Korch, biodefense rese...
Other Biology News:Primates on the brink 2Primates on the brink 3Primates on the brink 4NHGRI targets 12 more organisms for genome sequencing 2NHGRI targets 12 more organisms for genome sequencing 3NHGRI targets 12 more organisms for genome sequencing 4NHGRI targets 12 more organisms for genome sequencing 5Ancient immune defense mechanism is no match for HIV-1 2(Date:1/8/2009)...NGTON BEACH, California, and AMSTERDAM, January 8 ...lar cancer diagnostics, today announced the,appoi... new Chief Financial,Officer. , "Kurt is a...le asset,",said Bernhard Sixt, Ph.D., President a...inancial management experience in the high tech an...
(Date:1/8/2009)... Jan. 8 /PRNewswire/ - Aegera Therapeutics Inc. an... randomized Phase 2 study of AEG35156, their targe... for multiple oncology indications. , The study, ...omized Study of the X-Linked Inhibitor of Apoptosi...ith Carboplatin/Paclitaxel or the Combination of C...
(Date:1/8/2009)...Jan. 8 Dendreon Corporat...ent will present at the 27th Annual J.P. Morgan He...January 15, 2009 at 11:00 a.m. PT. , , , A l...ssible through the Investor Relations section of t... you are unable to listen to the live webcast, it ...
(Date:1/8/2009)... N.J., Jan. 8 Amicus The...ection of Sol J. Barer, Ph.D., to its Board of Dir...d Chief Executive Officer of Celgene Corporation. ...years of management experience and a reputation as...nsform Celgene into one of the world,s preeminent ...
Breaking Biology Technology:Agendia Appoints New Chief Financial Officer 2Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer 2Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors 2...adison, Wis. Third Wave Technologies is appoin...O transition, according to a press release. , ,Man...ext annual report is filed. Arora has held senior ...any. Former CFO James Herrmann is moving on. Grego.... , ,John Bellano, 37, is now vice president of sa...
...adison, Wis. Angel investments in 2005 added up ...lly much more, according to a report released on W...ugh Act 255 have let Wisconsin, for the first time...nts by individuals. "Even though it,s not entirely...f what,s going on in the individual sector," said ...
...As the topic of financing is vital to a biotech co...(and I use "biotech" in the broadest sense) compan...ising money due to the long product development cy...ital financing results for 2005. , ,Last week, we...Company,s data. Burrill,s perspective is more towa...
...adison, Wis. Sonic Foundry said its revenues for...year-to-year. The firm took in $1.9 million for th...,A company statement said revenue is expected to p...k-even sometime in the next three quarters. , ,For...loss was $1.6 million for the quarter, compared to...
Other Biology Technology:State tracks more angel investment, at least $19M last year 2U.S. VC funding flat in 2005 while life science funding grows 2U.S. VC funding flat in 2005 while life science funding grows 3U.S. VC funding flat in 2005 while life science funding grows 4Anti-Poly (ADP-Ribose) Polymerase from Roche Applied Science
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167
Mouse polyclonal antibody raised against a partial recombinant SLC22A3. Immunogen: SLC22A3 (NP_068812, 90 a.a. ~ 156 a.a) partial recombinant protein with GST tag. Accession Number: NM_021977
Propidium Iodide from Calbiochem
Biology Products: